๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice

โœ Scribed by Alun Morinan; Jonathan G. Collier

Publisher
Springer
Year
1981
Tongue
English
Weight
546 KB
Volume
75
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

โœฆ Synopsis

Mice pretreated with the monoamine oxidase inhibitor pargyline showed a dose-dependent increase in hyperactivity for up to 2 h following injections of N,Ndimethyltryptamine (DMT: 0.5-8.0 mg/kg). Hyperactivity was related to a linear increase in whole brain concentrations of DMT as measured by a new sensitive gas chromatographic assay. The duration of this behaviour paralleled the concentration of DMT in the brain from 15-120 min. However, at 15 rain, there was no significant difference in brain DMT concentrations between mice receiving pargyline and those given distilled water at the two dose levels of DMT studied (2.0 and 8.0 mg/kg). Pre-treatment with the microsomal enzyme inhibitor SKF-525A, alone or in combination with pargyline, had no effect on the DMT-induced behaviour or on the brain levels of DMT.

๐Ÿ“œ SIMILAR VOLUMES

Labeling in vivo of sigma receptors in m
Labeling in vivo of sigma receptors in mouse brain with [3H]-(+)-SKF 10,047: Effects of phencyclidine, (+)- and (โˆ’)-N-allylnormetazocine, and other drugs
โœ Dr. Robert M. Ferris; Anne Russell; Flora L. M. Tang; Phillip A. Topham ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 821 KB

Labeling in vivo of sigma receptors in mouse brain with [3H]-( +)-SKF 10,047: Effects of phencyclidine, ( + ) -and (-)-N-allylnormetazocine, and other drugs. Drug Dev. Res. 24:81-92, 1991. The sigma receptor, so named because of the distinct pharmacological profile produced by its prototypic agonist